4SCan/vADME: intelligent library screening as a shortcut from hits to lead compounds

Managing to solve the first step in drug discovery the hit finding can be a quite elaborate task, but it is only the initial step to the final goal; hit-to-lead optimisation still lies ahead and consumes even more time and resources. The solution is rather simple, that is, to take only the most promising compounds into account; but who is going to decide which ones are the most promising among a list of tens of millions of compounds in a virtual combinatorial library? 4SCan/vADME helps by bridging the gap between virtual (combinatorial) libraries designed by chemists and the insilico methods, docking and alignment, for screening databases. After choosing a random starting set, the implemented learning and prediction algorithm iteratively considers only combinations of fragments that have shown to result in more suitable interactions by the chosen method. ADME properties of the final list are then calculated via several insilico methods, resulting in a combined evaluation of the individual compounds target-specific, as well as ADME, properties. Based on the latter list of evaluated compounds, medicinal chemists can then decide which compounds might be the best ones to synthesise first and to serve as possible lead candidates. Following a brief introduction to virtual high-throughput screening techniques, the 4SCan/vADME method is outlined and discussed in this paper, using an example coming out of the 4SC pipeline.

[1]  Igor V. Tetko,et al.  Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices , 2001, J. Chem. Inf. Comput. Sci..

[2]  S. Nylander,et al.  Jejunal Permeability: A Comparison Between the Ussing Chamber Technique and the Single-Pass Perfusion in Humans , 1997, Pharmaceutical Research.

[3]  B. Faller,et al.  High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.

[4]  Daniel Vitt,et al.  Virtual high-throughput in silico screening , 2003 .

[5]  Gabriele Cruciani,et al.  Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. , 2003, Journal of medicinal chemistry.

[6]  H. Simmonds,et al.  Importance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans , 1995, The Journal of Biological Chemistry.

[7]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[8]  A. Link,et al.  A timely reassessment of early prediction in the bioavailability of orally administered drugs. , 2005, Angewandte Chemie.

[9]  Thierry Langer,et al.  Chemical feature-based pharmacophores and virtual library screening for discovery of new leads. , 2003, Current opinion in drug discovery & development.

[10]  Samuel H. Yalkowsky,et al.  Prediction of Drug Solubility by the General Solubility Equation (GSE) , 2001, J. Chem. Inf. Comput. Sci..

[11]  Teuvo Kohonen,et al.  Self-organized formation of topologically correct feature maps , 2004, Biological Cybernetics.

[12]  T. Langer,et al.  Virtual screening: an effective tool for lead structure discovery? , 2001, Current pharmaceutical design.

[13]  Tingjun Hou,et al.  Recent development and application of virtual screening in drug discovery: an overview. , 2004, Current pharmaceutical design.

[14]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[15]  Jyrki Taskinen,et al.  Aqueous Solubility Prediction of Drugs Based on Molecular Topology and Neural Network Modeling , 1998, J. Chem. Inf. Comput. Sci..

[16]  Johann Gasteiger,et al.  Neural Networks for Chemists: An Introduction , 1993 .

[17]  Samuel H. Yalkowsky,et al.  Estimation of the aqueous solubility of complex organic compounds , 1993 .

[18]  Ola Engkvist,et al.  High-Throughput, In Silico Prediction of Aqueous Solubility Based on One- and Two-Dimensional Descriptors , 2002, J. Chem. Inf. Comput. Sci..

[19]  J. Kovacs.  How Iron Activates O2 , 2003, Science.

[20]  Samuel H. Yalkowsky,et al.  Solubility and Solubilization in Aqueous Media , 1999 .

[21]  Andy Vinter,et al.  Peptides to non-peptides: leads from structureless virtual screening , 2004 .

[22]  Gerhard Klebe,et al.  Predicting binding modes, binding affinities and ‘hot spots’ for protein-ligand complexes using a knowledge-based scoring function , 2000 .

[23]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[24]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[25]  R. Baumgartner,et al.  Discovery of a novel series of DHODH inhibitors by a docking procedure and QSAR refinement. , 2004, Bioorganic & medicinal chemistry letters.

[26]  Eric F. Johnson,et al.  The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution* , 2004, Journal of Biological Chemistry.

[27]  Didier Rognan,et al.  Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? , 2002, Proteins.

[28]  I D Kuntz,et al.  CombiDOCK: Structure-based combinatorial docking and library design , 1998, Journal of computer-aided molecular design.

[29]  R. Sheridan,et al.  A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules. , 2003, Journal of medicinal chemistry.

[30]  Thomas Herz,et al.  ProPose: a docking engine based on a fully configurable protein–ligand interaction model , 2004, Journal of molecular modeling.

[31]  Barry C Jones,et al.  Development of a combined protein and pharmacophore model for cytochrome P450 2C9. , 2002, Journal of medicinal chemistry.

[32]  John S. Delaney,et al.  ESOL: Estimating Aqueous Solubility Directly from Molecular Structure , 2004, J. Chem. Inf. Model..

[33]  Y. Martin,et al.  A general and fast scoring function for protein-ligand interactions: a simplified potential approach. , 1999, Journal of medicinal chemistry.

[34]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery. 4. Prediction of Aqueous Solubility Based on Atom Contribution Approach , 2004, J. Chem. Inf. Model..

[35]  James W. McFarland,et al.  Estimating the Water Solubilities of Crystalline Compounds from Their Chemical Structures Alone , 2001, J. Chem. Inf. Comput. Sci..

[36]  Veerabahu Shanmugasundaram,et al.  Estimation of Aqueous Solubility of Organic Compounds with QSPR Approach , 2004, Pharmaceutical Research.

[37]  G. Klebe,et al.  Knowledge-based scoring function to predict protein-ligand interactions. , 2000, Journal of molecular biology.

[38]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[39]  Thomas Lengauer,et al.  A recursive algorithm for efficient combinatorial library docking , 2000 .

[40]  J. Gasteiger,et al.  Automatic generation of 3D-atomic coordinates for organic molecules , 1990 .

[41]  Tudor I. Oprea,et al.  Toward minimalistic modeling of oral drug absorption. , 1999, Journal of molecular graphics & modelling.

[42]  R. García-Domenech,et al.  Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. , 1999, Journal of medicinal chemistry.

[43]  H. Lohninger.  Neural Networks for Chemists. Von J. Zupan und J. Gasteiger. VCH Verlagsgesellschaft mbH 1993. 305 S., mit zahlr. Abb. und Tab., geb., DM 68,–. , 1994 .

[44]  J. Clardy,et al.  Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. , 2000, Structure.

[45]  Kenneth M Merz,et al.  Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships. , 2003, Journal of medicinal chemistry.

[46]  Andrew Smellie,et al.  Surrogate docking: structure-based virtual screening at high throughput speed , 2005, J. Comput. Aided Mol. Des..

[47]  Johann Gasteiger,et al.  Prediction of Aqueous Solubility of Organic Compounds Based on a 3D Structure Representation , 2003, J. Chem. Inf. Comput. Sci..

[48]  Petra Schneider,et al.  Comparison of correlation vector methods for ligand-based similarity searching , 2003, J. Comput. Aided Mol. Des..

[49]  M Rarey,et al.  Detailed analysis of scoring functions for virtual screening. , 2001, Journal of medicinal chemistry.

[50]  Frank E. Blaney,et al.  Crystal Structure of Human Cytochrome P450 2D6* , 2005, Journal of Biological Chemistry.

[51]  Hans-Joachim Böhm,et al.  Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs , 1998, J. Comput. Aided Mol. Des..

[52]  Colin McMartin,et al.  QXP: Powerful, rapid computer algorithms for structure-based drug design , 1997, J. Comput. Aided Mol. Des..

[53]  Markus H. J. Seifert,et al.  ProPose: Steered Virtual Screening by Simultaneous Protein-Ligand Docking and Ligand-Ligand Alignment , 2005, J. Chem. Inf. Model..

[54]  Jose Cosme,et al.  Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone , 2004, Science.

[55]  Christian Lemmen,et al.  Computational methods for the structural alignment of molecules , 2000, J. Comput. Aided Mol. Des..

[56]  Teuvo Kohonen,et al.  Self-Organization and Associative Memory, Third Edition , 1989, Springer Series in Information Sciences.

[57]  Jorma Laaksonen,et al.  SOM_PAK: The Self-Organizing Map Program Package , 1996 .

[58]  Kristina Luthman,et al.  Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans , 1997, Pharmaceutical Research.

[59]  Pierre Acklin,et al.  Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..

[60]  J. Jenkins,et al.  A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes. , 2004, Journal of medicinal chemistry.

[61]  Brian K. Shoichet,et al.  Virtual screening of chemical libraries , 2004, Nature.

[62]  Sean Ekins,et al.  KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4 , 2004, Drug Metabolism and Disposition.

[63]  Jose Cosme,et al.  Crystal structure of human cytochrome P450 2C9 with bound warfarin , 2003, Nature.

[64]  Marc Parham,et al.  Prediction of aqueous solubility based on large datasets using several QSPR models utilizing topological structure representation. , 2004, Chemistry & biodiversity.

[65]  H. Simmonds,et al.  T-lymphocytes from AIDS Patients Are Unable to Synthesize Ribonucleotides de Novo in Response to Mitogenic Stimulation , 1995, The Journal of Biological Chemistry.

[66]  T. Kohonen.  Self-Organized Formation of Correct Feature Maps , 1982 .

[67]  D. Rognan,et al.  Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.

[68]  Martin Stahl,et al.  Binding site characteristics in structure-based virtual screening: evaluation of current docking tools , 2003, Journal of molecular modeling.

[69]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[70]  Trevor Heritage,et al.  OptiDock: virtual HTS of combinatorial libraries by efficient sampling of binding modes in product space. , 2004, Journal of combinatorial chemistry.

[71]  Eric F. Johnson,et al.  The Structure of Human Microsomal Cytochrome P450 3A4 Determined by X-ray Crystallography to 2.05-Å Resolution* , 2004, Journal of Biological Chemistry.

[72]  Bernd Beck,et al.  Descriptors, physical properties, and drug-likeness. , 2002, Journal of medicinal chemistry.